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Foreword
MMWR Summary of Notifiable Diseases, United States, 1994
This publication contains summary tables of the official statistics for the reported
occurrence of nationally notifiable diseases in the United States for the year 1994. This
information is collected and compiled from reports to the National Notifiable Diseases
Surveillance System (NNDSS). Because the dates of onset and dates of diagnosis for
notifiable diseases are often unknown, these surveillance data are presented by the
week that they were reported to public health officials. These data are then finalized
and published in the MMWR Summary of Notifiable Diseases, United States, for use
by state and local health departments; schools of medicine and public health; commu-
nications media; local, state, and federal agencies; and other agencies or persons
interested in following the trends of reportable conditions in the United States. Publi-
cation of the annual summary also ensures documentation of diseases that are
considered national priorities for notification and of the annual number of cases of
such diseases.
Part 1 contains information on morbidity for each of the conditions considered na-
tionally notifiable during 1994. In all tables, leprosy is listed as Hansen disease and
typhus fever (tick-borne) as Rocky Mountain spotted fever (RMSF). The tables show
the number of cases of notifiable diseases reported to CDC for 1994, as well as the
distribution of cases by month and geographic location, and by patient’s age, race,
and ethnicity. The data are final totals as of July 7, 1995, unless otherwise noted.
Part 2 contains graphs and maps depicting summary data for many of the notifiable
conditions described in tabular form in Part I.
Part 3 includes tables showing the number of cases of notifiable diseases reported
to CDC and to the National Office of Vital Statistics since 1945. It also includes a table
on deaths associated with specified notifiable diseases reported to the National Cen-
ter for Health Statistics, CDC, for the period 1983–1992.
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Background
As of January 1, 1994, 49 infectious diseases were designated as notifiable at the
national level. A notifiable disease is one for which regular, frequent, and timely infor-
mation on individual cases is considered necessary for the prevention and control of
the disease. This section briefly summarizes the history of national notifiable disease
reporting in the United States.
In 1878, Congress authorized the U.S. Marine Hospital Service (the precursor to the
Public Health Service, PHS) to collect morbidity reports on cholera, smallpox, plague,
and yellow fever from U.S. consuls overseas; this information was to be used for insti-
tuting quarantine measures to prevent the introduction and spread of these diseases
into the United States. In 1879, a specific Congressional appropriation was made for
the collection and publication of reports of these notifiable diseases. The authority for
weekly reporting and publication was expanded by Congress in 1893 to include data
from states and municipal authorities. To increase the uniformity of the data, Congress
enacted a law in 1902 directing the Surgeon General to provide forms for the collec-
tion and compilation of data and for the publication of reports at the national level. In
1912, state and territorial health authorities—in conjunction with PHS—recommended
immediate telegraphic reporting of five infectious diseases and monthly reporting by
letter of 10 additional diseases. The first annual summary of The Notifiable Diseases
in 1912 included reports of 10 diseases from 19 states, the District of Columbia, and
Hawaii. By 1928, all states, the District of Columbia, Hawaii, and Puerto Rico were
participating in national reporting of nearly 30 specified conditions. At their annual
meeting in 1950, the State and Territorial Health Officers authorized a conference of
state and territorial epidemiologists whose purpose was to determine which diseases
should be reported to PHS. CDC assumed responsibility for the collection and publica-
tion of data on nationally notifiable diseases in 1961.
The list of nationally notifiable diseases is revised periodically. For example, dis-
eases may be added to the list as new pathogens emerge or deleted as their incidence
declines. Public health officials at state health departments and CDC continue to col-
laborate in determining which diseases should be nationally notifiable; the Council of
State and Territorial Epidemiologists (CSTE), with CDC input, makes recommenda-
tions annually for additions and deletions to the list of nationally notifiable diseases.
However, reporting of nationally notifiable diseases to CDC by the states is voluntary.
Reporting is currently mandated (by state legislation or regulation) only at the state
level. The list of diseases that are considered notifiable, therefore, varies slightly by
state. All states generally report the internationally quarantinable diseases (i.e., chol-
era, plague, and yellow fever) in compliance with the World Health Organization’s
International Health Regulations. During 1994, 49 infectious diseases were considered
notifiable at the national level and were reported to CDC; 41 were reported on a
weekly basis, and eight were reported monthly. 
CSTE and CDC held a national surveillance conference November 30-December 2,
1994 to review the state of national infectious disease surveillance. Infectious diseases
that have been approved for addition to national surveillance during 1995 are Chlamy-
dia trachomatis (genital infections), coccidioidomycosis (for regional surveillance),
cryptosporidiosis, hantavirus infection, (post-diarrheal) hemolytic uremic syndrome,
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pediatric infection with the human immunodeficiency virus, invasive group A
streptococcal infections, streptococcal toxic-shock syndrome, and drug-resistant
Streptococcus pneumoniae. These conditions currently are not reportable in all states,
and the mechanism for reporting may not involve clinicians or consist of reports of
individual cases (i.e., traditional notification methods).  Reports of the number of
cases of these conditions will not appear in the current year tables before 1996. 
At the 1994 conference the following diseases were also proposed as deletions
from the list of infectious diseases under national surveillance: amebiasis, aseptic
meningitis, primary encephalitis (except for arboviral encephalitis), postinfectious
encephalitis, granuloma inguinale, unspecified hepatitis, leptospirosis, lymphogranu-
loma venereum, rheumatic fever, and tularemia. These changes were confirmed by a
vote of the full membership of CSTE in early 1995. The number of reported cases of
these diseases will not appear in the current year tables after 1994. 
The list of 49 infectious diseases that were designated as notifiable at the national
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Data Sources
Provisional data on the reported occurrence of notifiable diseases are published
weekly in MMWR.  After each reporting year,  staff in state health departments finalize
reports of cases for the year with local or county health departments, as well as recon-
cile the data with reports previously sent to CDC throughout the year; these data are
compiled in final form in this summary.  Notifiable disease reports (published in the
annual MMWR Summary of Notifiable Diseases only after the approval of each state
epidemiologist) are the authoritative and archival counts of cases. MMWR Surveil-
lance Summaries or other surveillance reports produced by CDC programs, which are
useful for detailed epidemiologic analyses, may not agree exactly with numbers re-
ported in the annual Summary of Notifiable Diseases due to differences in the timing
of reports, the source of the data, and the use of different case definitions. 
Data in this summary are derived primarily from reports transmitted to the Division
of Surveillance and Epidemiology, Epidemiology Program Office, CDC, by the 50 state,
two city, and five territorial health departments through the National Electronic Tele-
communications System for Surveillance (NETSS).  Final data for other diseases are
from surveillance program records of the CDC programs listed below; requests for
further information regarding these data should be directed to the source specified. 
National Center for Health Statistics
Office of Vital and Health Statistics Systems (deaths from selected notifiable
diseases)
National Center for Infectious Diseases
Division of Bacterial and Mycotic Diseases (toxic-shock syndrome and laboratory
data on botulism, Escherichia coli O157:H7, Salmonella, and Shigella)
Division of HIV/AIDS (human immunodeficiency virus/acquired immunodeficiency
syndrome)
Division of Vector-Borne Infectious Diseases (laboratory data on arboviral
encephalitis)
Division of Viral and Rickettsial Diseases (animal rabies)
National Center for Prevention Services
Division of Sexually Transmitted Diseases and HIV Prevention (gonorrhea, syphilis,
chancroid, granuloma inguinale, and lymphogranuloma venereum)
Division of Tuberculosis Elimination (tuberculosis)
National Immunization Program
Epidemiology and Surveillance Division (poliomyelitis)
Disease totals for the United States, unless otherwise stated, do not include data
for American Samoa, Guam, Puerto Rico, the Virgin Islands, and the Commonwealth
of the Northern Mariana Islands (CNMI).
Data on notifiable diseases before 1960 (before CDC assumed responsibility for col-
lection and publication of these data) are obtained from publications of the National
Office of Vital Statistics. 
Population estimates for states are based on the July 1, 1994, post-censal estimates
made by the U.S. Department of Commerce, Bureau of the Census, Population Divi-
sion, Population Estimates Branch, Press Release CB94-204. 
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Population estimates for territories are from the 1990 census, U.S. Department of
Commerce, Bureau of the Census, Press Releases CB91-142, 242, 243, 263, and 276.
Rates in the 1994 Summary of Notifiable Diseases were based on data for the U.S.
total resident population. However, population data from states in which diseases
were not notifiable or disease data were not available were excluded from rate calcu-
lations. 
Interpreting Data
The data reported in this summary are useful for analyzing disease trends and de-
termining relative disease burdens. However, these data must be interpreted in light
of reporting practices. Some diseases that cause severe clinical illness (e.g., plague or
rabies), if diagnosed by a clinician, are most likely reported accurately. However, per-
sons who have diseases that are clinically mild and infrequently associated with
serious consequences (e.g., salmonellosis) may not even seek medical care from a
health-care provider; even if these diseases are diagnosed, they are less likely to be
reported. The degree of completeness of reporting also is influenced by the diagnostic
facilities available; the control measures in effect; the public awareness of a specific
disease; and the interests, resources, and priorities of state and local officials respon-
sible for disease control and public health surveillance. Finally, factors such as
changes in the case definitions for public health surveillance, the introduction of new
diagnostic tests, or the discovery of new disease entities may cause changes in dis-
ease reporting that are independent of the true incidence of disease. 
Public health surveillance data are published for selected racial and ethnic popula-
tion groups because these variables may be risk markers for certain notifiable
diseases. Risk markers can identify potential risk factors for investigation in future
studies. Data on race and ethnicity also can be useful for identifying groups to target
for prevention efforts. Year 2000 objectives for racial and ethnic groups (standardized
to the 1940 U.S. population) have been established for several of the notifiable dis-
eases.
 
EXPLANATION OF SYMBOLS USED IN
TABLES, GRAPHS, AND MAPS
Data not available ............................................. NA
No reported cases............................................... –  




HIGHLIGHTS FOR SELECTED INFECTIOUS DISEASES
NOT NATIONALLY NOTIFIABLE DURING 1994
Chlamydia
Chlamydia trachomatis infections are common among adolescents and young
adults. An estimated 10% of sexually active adolescent females are infected with
chlamydia. In 1994, 47 states reported 448,984 chlamydia infections. From 1984
through 1994, reported cases increased from 3.2 cases per 100,000 to 188.4. This trend
may reflect increasing recognition and interest among health-care providers and pub-
lic health officials.
Coccidioidomycosis
An outbreak of coccidioidomycosis occurred in Ventura County, California, follow-
ing the 1994 Northridge earthquake. From January 24 through March 15, 1994,
203 infected persons were identified, compared with 52 cases that were reported
through passive surveillance in the county in 1993. The National Center for Infectious
Diseases (NCID/CDC) Emerging Infections Program (EIP), in collaboration with the
State of California Department of Health Services, is conducting active surveillance for
coccidioidomycosis in 10 California counties.
Cryptosporidiosis
In 1994, waterborne outbreaks of cryptosporidiosis were investigated in Las Vegas,
Nevada, Walla Walla, Washington, and Lake Nummy, New Jersey, focusing na-
tional attention on the potential for waterborne transmission of Cryptosporidium. In
September 1994, a national workshop on waterborne cryptosporidiosis was held at
CDC, which resulted in guidelines and recommendations for prevention of crypto-
sporidiosis in severely immunosuppressed persons, appropriate public health
responses to the problem, and epidemiologic and laboratory-based surveillance and
research.
Hantavirus
Hantavirus Pulmonary Syndrome (HPS) is a recently recognized hantaviral illness
caused by Sin Nombre virus and the newly identified Black Creek Canal and Bayou
viruses. The identified rodent reservoirs for these viruses — Peromyscus maniculatus
and leucopus (deer and white-footed mice) for Sin Nombre virus and its variants and
Sigmodon hispidus (cotton rat) for Black Creek Canal virus — extend across the conti-
nental United States. As of July 20, 1995, national surveillance for HPS has identified
113 confirmed case-patients in 23 states (case fatality rate: 52%); 31 of these cases
occurred in 1994.
Invasive group A streptococcal infections
Prospective and retrospective active surveillance data for invasive group A strepto-
coccal (GAS) infections were analyzed and several risk groups identified, including:
persons who have human immunodeficiency virus (HIV) infections and acquired im-
munodeficiency syndrome (AIDS), injecting-drug users, persons who have cancer,
diabetes mellitus, heart disease or chronic lung disease, alcohol abusers, and children
who have varicella. Although different GAS strains have been identified from individ-
ual case patients, M-type 1 strains predominated.
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Drug-resistant Streptococcus pneumoniae
In the United States, the prevalence of drug-resistant Streptococcus pneumoniae
(DRSP) has increased since 1987 from 3.6% to 14.5%, according to limited voluntary
reporting by 12 sentinel hospitals. Limited 1994 surveillance data from these hospitals
indicate the proportion of invasive disease (bacteremia and meningitis) caused by
penicillin-resistant pneumococci ranges from 3% to 30% and shows widespread geo-
graphic variation. Information regarding community-specific DRSP prevalence is
needed to assist clinicians in choosing optimal empiric therapy. To enhance efficient
and timely reporting, CDC is currently piloting an electronic laboratory-based surveil-
lance system.
Vancomycin-resistant enterococci
In 1994, the percentage of nosocomial enterococci reported as resistant to van-
comycin increased from 11.5% in 1993 to 13.6% among Intensive Care Unit (ICU)
isolates and from 4.9% to 9.1% among noncritical care unit isolates. The increase was
more dramatic among isolates from noncritical care units, suggesting that vancomy-
cin-resistant enterococci are spreading from their focus in ICUs. 
Pneumonia of unknown etiology
From 1979 to 1994, the overall crude death rate for pneumonia and influenza in-
creased 59%, from 20.0 to 31.8 deaths per 100,000. Through 1992 (the most recent
year for which complete data are available), pneumonia of unspecified etiology (ICD-9
code 486) accounted for most of the overall increase—the age-adjusted death rates in
this diagnostic category increased 74%. Since the 1970s, several previously unrecog-
nized infectious agents have been identified as causes of lower respiratory infections,
including Legionella pneumophila, Chlamydia pneumoniae, and Sin Nombre virus.
Recent prospective studies of community-acquired pneumonia indicate that an etiol-
ogy cannot be identified in up to 50% of cases.
Transfusion-associated infectious diseases
An Institute of Medicine committee recently released the report, “HIV and the
Blood Supply: An Analysis of Crisis Decisionmaking,” calling for the establishment of
a surveillance system at CDC to detect, monitor, and warn of adverse effects in the
recipients of blood and blood products. CDC is reviewing existing surveillance sys-
tems to highlight and address areas that need improvement. Diseases that are being
examined to evaluate the level of risk associated with transfusion include HIV/AIDS,




Although dengue fever is not endemic in the United States, its incidence is increas-
ing in most tropical areas throughout the world. In 1994, CDC processed serum
samples from 91 residents of 27 states and the District of Columbia who had travelled
to countries where dengue is endemic. Among these 91 persons, 37 (40.7%) cases of
dengue were diagnosed serologically or virologically.
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Plague
During September and October 1994, outbreaks of bubonic and pneumonic plague
were reported from sites east and north of Bombay, India, respectively. A lack of reli-
able epidemiologic information contributed to the ensuing international health
emergency. Evidence revealed that plague did not occur in international travelers or
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NAME Total Jan. Feb. Mar. Apr. May June July Aug. Sept. Oct. Nov. Dec. Unk.
AIDS* 78,279 7,058 4,446 8,774 5,954 6,136 7,100 6,305 7,814 7,563 5,800 6,056 5,273 -
Amebiasis 2,983 158 167 196 315 215 258 226 281 197 280 202 488 -
Anthrax - - - - - - - - - - - - - -
Aseptic meningitis 8,932 351 322 423 516 497 690 1,043 1,067 1,030 1,086 7,180 1,189 -
Botulism, total 143 13 8 12 7 19 19 11 12 8 15 9 10 -
Brucellosis 119 4 3 6 9 8 5 18 11 10 1 9 35 -
Chancroid† 773 ..............................198 ................................................ 204.................................................182 ................................................ 189 ................. -
Cholera 39 - 2 3 3 1 5 1 3 1 4 8 8 -
Diphtheria 2 - - 2 - - - - - - - - - -
Encephalitis, primary infections 717 42 56 43 47 36 43 67 66 86 80 52 99 -
  Post-infectious 143 7 9 12 17 8 13 14 12 10 12 11 18 -
Escherichia coli  O157:H7 1,420 14 28 23 51 75 88 227 208 150 195 139 222 -
Gonorrhea† 418,068 ........................ 92,183 ...........................................99,347......................................... 111,415 .........................................115,123 ................. -
Granuloma inguinale† 3 ..................................1 ..................................................... -.....................................................1 .................................................... 1 ................. -
Haemophilus influenzae, invasive 1,174 84 98 91 107 145 72 111 55 69 107 69 166 -
Hansen disease (leprosy) 136 11 7 7 17 5 15 18 8 6 15 12 15 -
Hepatitis A 26,796 1,235 1,788 1,669 2,250 1,863 1,835 2,597 2,042 2,191 2,820 2,128 4,378 -
Hepatitis B 12,517 708 936 959 1,159 906 834 1,093 891 883 1,054 975 2,119 -
Hepatitis, C/non-A non-B 4,470 309 276 388 375 296 361 352 297 387 329 318 782 -
Hepatitis, unspecified 444 21 30 22 48 34 38 42 33 38 39 32 67 -
Legionellosis 1,615 85 112 105 141 100 122 161 175 145 148 120 201 -
Leptospirosis 38 6 1 1 5 - - 4 2 6 6 3 4 -
Lyme disease 13,043 386 260 377 513 450 831 2,622 1,841 1,528 1,549 1,158 1,528 -
Lymphogranuloma venereum† 235 ................................74 .................................................. 54...................................................52 .................................................. 55 ................. -
Malaria 1,229 48 91 99 85 56 71 101 126 104 122 70 256 -
Measles (rubeola) 963 6 38 67 241 298 97 71 15 23 19 11 77 -
Meningococcal disease 2,886 245 278 274 290 285 198 212 140 124 199 197 444 -
Mumps 1,537 71 123 108 153 134 114 126 163 70 141 90 244 -
Pertussis (whooping cough) 4,617 257 344 260 274 281 274 362 402 306 603 312 942 -
Plague  17 1 - - - 2 6 6 1 - - 1 - -
Poliomyelitis, paralytic§ - - - - - - - - - - - - - -
Psittacosis 38 3 5 4 - 4 4 6 1 2 3 1 5 -
Rabies, animal 8,147 474 500 867 759 667 692 628 845 764 759 645 547 -
Rabies, human 6 1 - - - - 1 - - - 2 2 - -
Rheumatic fever, acute 112 6 3 8 13 6 29 7 5 3 10 6 16 -
Rocky Mountain spotted fever 465 5 6 11 18 20 54 82 84 46 57 28 54 -
Rubella (German measles) 227 3 31 50 50 12 25 27 4 5 2 2 16 -
Rubella, congenital syndrome 7 - 2 - - - - - - 1 - 2 2 -
Salmonellosis 43,323 1,560 1,656 1,899 2,799 2,529 3,040 4,776 4,666 4,436 6,057 3,620 6,275 -
Shigellosis 29,769 1,293 1,406 1,734 2,319 2,070 2,126 2,969 2,597 2,543 3,190 2,541 4,981 -
Syphilis, total all stages† 81,696 ........................ 20,981 ...........................................21,544........................................... 20,462 ...........................................18,709 ................. -
  Primary and secondary† 20,627 .......................... 5,308 .............................................5,154............................................. 5,396 .............................................4,769 ................. -
  Congenital  <1 year† 2,204 ..............................535 ................................................ 597.................................................525 ................................................ 547 ................. -
Tetanus 51 1 2 4 4 3 4 3 1 5 8 3 13 -
Toxic-shock syndrome 192 13 21 13 28 16 11 10 19 14 13 11 23 -
Trichinosis 32 10 3 3 5 - - - 2 - 2 5 2 -
Tuberculosis 24,361 567 1,302 1,877 2,138 1,949 2,105 2,063 1,964 2,009 1,860 1,906 4,621 -
Tularemia 96 - 1 - 1 7 14 24 10 14 7 - 18 -
Typhoid fever 441 17 29 35 51 39 32 44 33 53 43 18 47 -
Varicella (chickenpox) 151,219 11,939 14,564 19,132 27,154 22,550 19,723 6,554 2,238 1,994 4,241 7,415 13,715 -
 §Two suspected cases of paralytic poliomyelitis were reported in 1994. Confirmation of these cases is pending
review by external panel.
* AIDS total updated through December 31, 1994.
† Cases updated through Feburary 28, 1995.
NOTIFIABLE DISEASES — Summary of reported cases, by month, United States, 1994
United States 260,341 78,279* 2,983 - 8,932 50 85 119 773
†
New England 13,270 2,836 80 - 340 - 1 - 1
Maine 1,240 117 10 - 33 - - - -
N.H. 1,137 92 2 - 47 - - - -
Vt. 580 38 3 - 36 - - - -
Mass. 6,041 1,401 61 - 103 - - - 1
R.I. 997 276 4 - 121 - - - -
Conn. 3,275 912 NN - NN - 1 - -
Mid. Atlantic 38,125 22,465 876 - 957 2 16 2 365
N.Y. (excl. NYC) 10,905 2,220 120 - 466 1 - - 8
N.Y.C. 7,264 12,724 701 - 150 - 1 - 357
N.J. 7,904 4,993 25 - NN - 2 - -
Pa. 12,052 2,528 30 - 341 1 13 2 -
E.N. Central 43,184 6,324 187 - 1,652 2 9 8 48
Ohio 11,102 1,184 22 - 399 1 4 2 8
Ind. 5,752 622 21 - 222 - 2 - -
Ill. 11,752 3,104 45 - 472 1 2 5 38
Mich. 9,496 1,035 42 - 538 - 1 1 -
Wis. 5,082 379 57 - 21 - - - 2
W.N. Central 18,210 1,638 131 - 476 - 2 1 8
Minn. 4,567 422 39 - 43 - - - -
Iowa 2,829 130 21 - 121 - - 1 1
Mo. 5,278 713 38 - 175 - - - 2
N. Dak. 638 20 8 - 14 - - - -
S. Dak. 721 19 4 - 3 - - - -
Nebr. 1,623 89 6 - 41 - - - -
Kans. 2,554 245 15 - 79 - 2 - 5
S. Atlantic 46,398 18,857 203 - 2,000 - 4 17 30
Del. 706 271 3 - 41 - 1 - -
Md. 5,006 2,722 14 - 246 - 1 1 -
D.C. 570 1,399 2 - 53 - - - -
Va. 6,552 1,162 39 - 337 - 2 2 -
W. Va. 1,822 96 6 - 39 - - - -
N.C. 7,070 1,187 19 - 240 - - 3 10
S.C. 3,664 1,158 NN - 31 - - - -
Ga. 7,055 2,245 58 - 80 - - 3 -
Fla. 13,953 8,617 62 - 933 - - 8 20
E.S. Central 15,890 2,099 10 - 582 3 3 2 27
Ky. 3,827 320 6 - 181 - 1 - -
Tenn. 5,175 764 NN - 164 2 1 1 3
Ala. 4,219 582 3 - 174 - - - 24
Miss. 2,669 433 1 - 63 1 1 1 -
W.S. Central 28,404 7,671 124 - 1,072 25 4 32 260
Ark. 2,453 284 4 - 62 - 1 1 -
La. 4,315 1,239 2 - 40 - - 2 209
Okla. 3,258 269 8 - - 1 - - -
Tex. 18,378 5,879 110 - 970 24 3 29 51
Mountain 15,215 2,287 150 - 353 - 8 20 3
Mont. 856 30 - - 8 - 1 - -
Idaho 1,133 61 6 - 6 - 2 - -
Wyo. 476 18 - - 4 - 1 - -
Colo. 3,656 816 39 - 135 - 1 1 -
N. Mex. 1,654 211 27 - 20 - - 1 -
Ariz. 4,075 612 61 - 79 - - 17 3
Utah 1,908 152 6 - 55 - 3 1 -
Nev. 1,457 387 11 - 46 - - - -
Pacific 41,645 13,949 1,222 - 1,500 18 38 37 31
Wash. 5,343 932 78 - NN 3 2 - 1
Oreg. 3,086 606 109 - NN - 3 1 5
Calif. 31,431 12,136 991 - 1,350 4 30 36 25
Alaska 606 59 5 - 19 11 - - -
Hawaii 1,179 216 39 - 131 - 3 - -
Guam 133 1 1 - 13 - - - -
P.R. 3,522 2,359 1 - 72 - - - 32
V.I. 102 52 - - - - - - 1
C.N.M.I. 43 - - - - - - - -













*Total reported to Division of HIV/AIDS Prevention, National Center for Prevention Services, through December 31, 1994. Total
includes 153 cases with unknown state of residence.
†Cases updated through Division of Sexually Transmitted Diseases and HIV Prevention, National Center for Prevention Services,
as of February 28, 1995.
NOTIFIABLE DISEASES — Reported cases, by geographic division and area,
United States, 1994
SUMMARY TABLES — 1994
4
United States 39 2 717 143 1,420 418,068* 3* 1,174 136
New England 2 1 18 6 223 8,640 - 45 4
Maine - - 5 - NN 93 - 5 -
N.H. - - - 2 NN 103 - 4 -
Vt. - - 3 1 12 40 - - -
Mass. 1 1 8 1 134 3,159 - 21 4
R.I. - - 2 2 9 478 - 4 -
Conn. 1 - - - 68 4,767 - 11 -
Mid. Atlantic 6 - 63 20 160 49,450 - 149 16
N.Y. (excl. NYC) 3 - 38 3 149 11,506 - 70 2
N.Y.C. 1 - 6 5 11 19,491 - 34 13
N.J. 2 - - - - 5,269 - 16 1
Pa. - - 19 12 NN 13,184 - 29 -
E.N. Central 5 - 169 22 269 87,065 - 199 9
Ohio - - 55 4 109 24,746 - 109 -
Ind. - - 11 1 57 9,757 - 26 -
Ill. 2 - 65 5 103 26,571 - 43 6
Mich. 3 - 38 12 - 18,215 - 19 -
Wis. - - - - NN 7,776 - 2 3
W.N. Central 1 - 52 12 366 22,834 - 103 -
Minn. - - 22 - 147 3,346 - 34 -
Iowa 1 - 1 1 56 1,645 - 9 -
Mo. - - 8 6 40 12,557 - 51 -
N. Dak. - - 4 - 31 35 - - -
S. Dak. - - 4 - 18 243 - 2 -
Nebr. - - 6 5 74 1,335 - 4 -
Kans. - - 7 - NN 3,673 - 3 -
S. Atlantic 3 - 161 65 23 104,591 2 234 2
Del. - - 1 - NN 2,038 - 1 -
Md. 1 - 28 5 NN 15,137 - 87 -
D.C. - - - 1 - 6,827 - - -
Va. 1 - 34 6 NN 13,414 - 22 1
W. Va. - - 51 - NN 805 - 7 -
N.C. - - 44 1 6 28,936 2 32 -
S.C. - - - - 17 13,067 - 3 -
Ga. - - 2 - NN NA - 67 -
Fla. 1 - 1 52 - 24,367 - 15 1
E.S. Central - - 41 4 6 48,208 - 34 1
Ky. - - 16 2 6 5,127 - 4 1
Tenn. - - 12 - NN 15,745 - 10 -
Ala. - - 9 1 - 15,881 - 15 -
Miss. - - 4 1 - 11,455 - 5 -
W.S. Central 4 - 63 2 98 53,529 - 74 33
Ark. - - 1 - 10 6,892 - 5 2
La. - - 10 - - 11,992 - 4 -
Okla. - - - - 16 4,888 - 45 -
Tex. 4 - 52 2 72 29,757 - 20 31
Mountain - - 14 3 100 10,669 - 128 -
Mont. - - - - - 85 - 1 -
Idaho - - - - - 98 - 5 -
Wyo. - - 3 1 NN 82 - 5 -
Colo. - - 4 - 76 3,632 - 17 -
N. Mex. - - - - - 1,130 - 12 -
Ariz. - - - 1 NN 3,603 - 26 -
Utah - - 3 1 NN 303 - 10 -
Nev. - - 4 - 24 1,736 - 52 -
Pacific 18 1 136 9 175 33,082 1 208 71
Wash. - - 1 - 174 2,893 - 10 7
Oreg. - - - - 1 978 1 26 -
Calif. 17 1 131 8 NN 27,593 - 165 43
Alaska - - 4 - NN 918 - 3 -
Hawaii 1 - - 1 NN 700 - 4 21
Guam 1 - - 1 NN 110 - - 11
P.R. - - 1 3 NN 500 - 3 1
V.I. - - - - - 60 - - -
C.N.M.I. - - - - - - - 26 -





















*Cases updated through Division of Sexually Transmitted Diseases and HIV Prevention, National Center for Prevention Services,
as of February 28, 1995.
NOTIFIABLE DISEASES — Reported cases, by geographic division and area,
United States, 1994 (continued)
SUMMARY TABLES — 1994
5
United States 26,796 12,517 4,470 444 1,615 38 13,043 235*
New England 296 354 168 15 79 3 2,827 6
Maine 25 11 - - 5 2 33 -
N.H. 17 28 11 - - - 30 -
Vt. 14 12 16 - 1 - 16 -
Mass. 112 200 121 13 55 - 247 6
R.I. 30 8 20 2 18 - 471 -
Conn. 98 95 - - NN 1 2,030 -
Mid. Atlantic 2,007 1,761 489 10 264 2 8,171 108
N.Y. (excl. NYC) 543 402 230 6 62 1 5,105 2
N.Y.C. 941 543 4 - 11 - 95 106
N.J. 306 410 211 - 49 1 1,533 -
Pa. 217 406 44 4 142 - 1,438 -
E.N. Central 2,777 1,221 320 16 433 1 530 9
Ohio 1,203 164 24 - 194 - 45 9
Ind. 361 215 9 - 48 - 19 -
Ill. 615 315 81 9 44 1 24 -
Mich. 352 432 206 7 82 - 33 -
Wis. 246 95 - - 65 - 409 -
W.N. Central 1,222 714 100 12 106 2 347 2
Minn. 261 82 20 - 4 - 208 -
Iowa 64 27 14 11 34 - 17 -
Mo. 619 538 32 1 41 1 102 2
N. Dak. 6 1 1 - 4 - - -
S. Dak. 39 4 - - 2 - - -
Nebr. 122 31 15 - 15 1 3 -
Kans. 111 31 18 - 6 - 17 -
S. Atlantic 1,466 2,240 485 32 413 3 855 65
Del. 22 14 2 - 31 - 106 -
Md. 198 354 21 8 82 1 341 -
D.C. 27 53 2 - 9 - 9 15
Va. 193 142 26 10 17 - 131 -
W. Va. 23 48 47 - 4 - 29 -
N.C. 145 291 59 - 28 1 77 44
S.C. 40 33 10 - 29 - 7 -
Ga. 43 555 220 - 118 - 127 3
Fla. 775 750 98 14 95 1 28 3
E.S. Central 784 1,211 945 2 83 3 43 2
Ky. 221 78 32 - 9 1 24 -
Tenn. 347 1,042 893 1 45 2 13 1
Ala. 139 91 20 1 13 - 6 1
Miss. 77 - - - 16 - - -
W.S. Central 3,719 1,830 599 94 63 1 174 12
Ark. 253 60 8 3 16 1 15 -
La. 170 203 215 2 20 - 4 12
Okla. 419 141 62 3 12 - 99 -
Tex. 2,877 1,426 314 86 15 - 56 -
Mountain 5,296 694 454 73 97 - 18 7
Mont. 25 21 13 - 16 - - -
Idaho 380 77 71 1 2 - 3 -
Wyo. 41 24 177 - 5 - 5 -
Colo. 584 97 79 14 19 - 1 1
N. Mex. 1,100 218 45 11 4 - 5 -
Ariz. 2,159 102 31 27 17 - - 5
Utah 754 96 18 6 8 - 3 -
Nev. 253 59 20 14 26 - 1 1
Pacific 9,229 2,492 910 190 77 23 78 24
Wash. 1,119 255 294 9 13 - 4 3
Oreg. 1,241 158 46 2 - 1 6 2
Calif. 6,602 2,038 565 176 59 - 68 19
Alaska 209 13 - - - - - -
Hawaii 58 28 5 3 5 22 - -
Guam 23 5 - 9 1 - - -
P.R. 86 415 215 3 - 2 - -
V.I. 3 9 1 - - - - -
C.N.M.I. 12 1 - - - - - -
















*Cases updated through Division of Sexually Transmitted Diseases and HIV Prevention, National Center for Prevention Services,
as of February 28, 1995.
NOTIFIABLE DISEASES — Reported cases, by geographic division and area,
United States, 1994 (continued)
SUMMARY TABLES — 1994
6
United States 1,229 746 217* 2,886 1,537 4,617 17 -
New England 78 15 12 141 26 760 - -
Maine 6 2 3 23 3 21 - -
N.H. 3 1 - 8 4 107 - -
Vt. 3 2 1 5 - 46 - -
Mass. 38 1 6 68 3 534 - -
R.I. 10 5 2 - 4 8 - -
Conn. 18 4 - 37 12 44 - -
Mid. Atlantic 261 200 27 312 116 695 - -
N.Y. (excl. NYC) 60 12 16 105 33 254 - -
N.Y.C. 106 11 4 40 12 224 - -
N.J. 57 172 3 65 13 15 - -
Pa. 38 5 4 102 58 202 - -
E.N. Central 117 60 46 397 267 615 - -
Ohio 20 15 2 121 77 162 - -
Ind. 15 - 1 55 7 97 - -
Ill. 48 18 41 125 110 111 - -
Mich. 31 24 2 59 59 96 - -
Wis. 3 3 - 37 14 149 - -
W.N. Central 48 127 44 174 71 273 - -
Minn. 16 - - 23 5 142 - -
Iowa 5 6 1 21 16 23 - -
Mo. 14 119 42 78 44 45 - -
N. Dak. 1 - - 1 4 5 - -
S. Dak. - - - 9 - 26 - -
Nebr. 5 1 1 14 1 14 - -
Kans. 7 1 - 28 1 18 - -
S. Atlantic 247 65 9 455 257 431 - -
Del. 3 - - 5 - 3 - -
Md. 83 2 2 35 65 74 - -
D.C. 15 - - 7 - 11 - -
Va. 37 1 2 69 48 37 - -
W. Va. - 37 - 14 5 6 - -
N.C. 12 2 1 57 73 140 - -
S.C. 5 - - 40 8 14 - -
Ga. 43 5 - 82 18 37 - -
Fla. 49 18 4 146 40 109 - -
E.S. Central 32 28 - 195 32 129 - -
Ky. 12 - - 42 - 60 - -
Tenn. 10 28 - 40 9 22 - -
Ala. 9 - - 77 12 35 - -
Miss. 1 - - 36 11 12 - -
W.S. Central 119 16 7 392 302 246 - -
Ark. 5 5 - 55 7 33 - -
La. 12 - 1 47 38 15 - -
Okla. 9 - - 53 23 38 - -
Tex. 93 11 6 237 234 160 - -
Mountain 41 163 55 178 162 609 15 -
Mont. - - - 6 - 12 - -
Idaho 2 1 - 17 10 172 - -
Wyo. 1 - - 9 3 - - -
Colo. 19 24 37 41 4 228 2 -
N. Mex. 3 2 - 17 NN 35 7 -
Ariz. 10 5 4 58 99 122 5 -
Utah 4 131 5 19 28 37 1 -
Nev. 2 - 9 11 18 3 - -
Pacific 286 72 17 642 304 859 2 -
Wash. 45 3 1 111 23 140 - -
Oreg. 17 - 2 143 NN 106 - -
Calif. 207 51 10 374 258 594 2 -
Alaska 2 10 - 5 4 - - -
Hawaii 15 8 4 9 19 19 - -
Guam - 228 - 2 7 2 - -
P.R. 5 46 - 7 2 3 - -
V.I. 1 - - - 4 - - -
C.N.M.I. 1 29 - - 2 - - -











*For 1994, includes both 142 cases of out-of-state importations and 75 cases of international importations.
†Two suspected cases of paralytic poliomyelitis were reported in 1994. Confirmation of these cases is pending review by external
panel.
NOTIFIABLE DISEASES — Reported cases, by geographic division and area,
United States, 1994 (continued)
SUMMARY TABLES — 1994
7
United States 38 8,147 6 112 465 227 7 43,323 29,769
New England 2 2,009 - 2 12 132 2 3,439 508
Maine - 10 - 1 - - - 191 10
N.H. 1 221 - NN - - - 213 20
Vt. 1 143 - - - - - 119 4
Mass. - 734 - 1 4 126 2 2,009 243
R.I. - 153 - - - 3 - 248 55
Conn. - 748 - - 8 3 - 659 176
Mid. Atlantic 6 2,249 - 5 24 8 - 7,066 3,163
N.Y. (excl. NYC) 1 1,569 - NN 8 6 - 1,977 1,120
N.Y.C. - 16 - NN 3 1 - 1,889 1,007
N.J. 1 278 - 5 5 1 - 1,160 522
Pa. 4 386 - NN 8 - - 2,040 514
E.N. Central 7 69 - 30 40 10 - 5,678 3,648
Ohio - 4 - 8 19 - - 1,337 740
Ind. 1 14 - 2 8 - - 581 544
Ill. - 21 - 8 11 1 - 1,821 1,494
Mich. 3 14 - 8 2 9 - 869 432
Wis. 3 16 - 4 - - - 1,070 438
W.N. Central 4 232 - 12 42 2 - 2,624 2,361
Minn. - 22 - 3 1 - - 759 554
Iowa - 90 - 3 1 - - 404 338
Mo. 4 27 - 3 22 2 - 642 654
N. Dak. - 14 - NN - - - 68 59
S. Dak. - 44 - 2 13 - - 143 207
Nebr. - - - NN 1 - - 209 426
Kans. - 35 - 1 4 - - 399 123
S. Atlantic 4 2,083 2 - 224 22 - 9,165 8,352
Del. - 74 - NN 1 - - 168 38
Md. 2 520 - NN 21 - - 1,178 323
D.C. - 4 - NN - - - 118 70
Va. 2 428 - NN 22 - - 1,135 656
W. Va. - 84 1 - 2 - - 152 15
N.C. - 175 - NN 88 - - 1,137 1,970
S.C. - 179 - NN 20 - - 599 505
Ga. - 367 - NN 62 7 - 1,583 1,886
Fla. - 252 1 NN 8 15 - 3,095 2,889
E.S. Central 1 242 2 - 47 - - 1,777 1,706
Ky. - 28 - NN 10 - - 380 208
Tenn. - 82 1 NN 29 - - 441 418
Ala. 1 128 1 NN 2 - - 507 617
Miss. - 4 - - 6 NN - 449 463
W.S. Central - 741 1 1 63 13 1 3,578 3,259
Ark. - 38 - 1 18 - - 534 193
La. - 73 - NN 1 - - 591 416
Okla. - 39 - NN 37 4 - 470 240
Tex. - 591 1 NN 7 9 1 1,983 2,410
Mountain 3 154 - 39 13 5 2 2,226 1,953
Mont. - 22 - NN 4 - - 145 4
Idaho - 4 - 1 - - - 130 59
Wyo. - 24 - 1 2 - - 60 8
Colo. 3 18 - 8 4 - - 709 530
N. Mex. - 8 - 1 1 - 1 353 347
Ariz. - 56 - NN 1 - 1 427 680
Utah - 13 - 28 - 4 - 202 240
Nev. - 9 - NN 1 1 - 200 85
Pacific 11 368 1 23 - 35 2 7,770 4,819
Wash. 4 15 - - - - - 863 478
Oreg. 2 13 - NN - 4 - 313 165
Calif. 4 294 1 18 - 27 2 6,235 3,953
Alaska 1 46 - 5 - - - 55 21
Hawaii - - - NN - 4 - 304 202
Guam - - - 3 - 1 - 76 33
P.R. - 77 - - - - - 737 48
V.I. - - - - - - - 2 4
C.N.M.I. - - - 4 - - - 78 60















*Rocky Mountain spotted fever.
NOTIFIABLE DISEASES — Reported cases, by geographic division and area,
United States, 1994 (continued)
SUMMARY TABLES — 1994
8
United States 20,627* 2,204* 81,696* 51 192 32 24,361 96 441 151,219
New England 219 14 1,128 2 5 1 595 1 25 11,676
Maine 4 - 9 - 1 1 35 - - 711
N.H. 4 - 18 1 - - 17 - - 3,408
Vt. - - 1 - 2 - 10 - - NN
Mass. 90 6 622 - 2 - 329 1 20 5,903
R.I. 16 2 141 - - - 56 - 1 1,654
Conn. 105 6 337 1 - - 148 - 4 NN
Mid. Atlantic 1,446 681 14,302 7 30 5 5,112 2 121 5,978
N.Y. (excl. NYC) 173 59 1,375 3 16 2 641 1 12 NN
N.Y.C. 629 329 8,001 - - - 2,995 1 78 5,978
N.J. 240 178 2,188 2 - 2 855 - 25 NN
Pa. 404 115 2,738 2 14 1 621 - 6 NN
E.N. Central 3,162 386 9,492 8 43 3 2,236 6 68 77,332
Ohio 1,187 71 2,740 1 10 - 337 1 7 5,495
Ind. 286 11 844 2 3 - 211 - 4 NN
Ill. 1,099 258 3,877 1 15 - 1,117 3 42 33,889
Mich. 292 28 1,234 4 15 1 462 1 6 37,948
Wis. 298 18 797 - - 2 109 1 9 NA
W.N. Central 1,203 82 2,663 4 28 2 610 38 2 18,210
Minn. 56 2 201 1 2 - 140 1 1 NN
Iowa 75 6 235 1 8 1 66 - - 4,197
Mo. 987 72 1,985 1 7 1 260 24 1 10,147
N. Dak. - - 1 - 1 - 10 1 - 48
S. Dak. 2 - 8 - - - 28 2 - 619
Nebr. 10 - 46 - 5 - 22 3 - 2
Kans. 73 2 187 1 5 - 84 7 - 3,197
S. Atlantic 5,362 322 18,942 7 12 1 4,448 2 56 8,653
Del. 27 5 138 - - - 57 - 1 2
Md. 325 9 1,538 1 - - 363 1 14 NN
D.C. 170 28 967 - - - 121 - 1 16
Va. 796 18 1,919 2 1 - 372 - 9 2,844
W. Va. 8 2 179 - - - 80 - - 5,656
N.C. 1,672 44 4,023 1 1 - 566 - 1 NN
S.C. 799 100 1,945 1 - - 387 NN - 135
Ga. 820 42 3,185 - 1 1 740 1 2 NN
Fla. 745 74 5,048 2 9 - 1,762 - 28 NN
E.S. Central 3,997 144 9,992 - 6 - 1,578 3 6 4,701
Ky. 208 13 534 - 2 - 347 2 1 984
Tenn. 1,044 57 2,978 - 2 - 520 - 3 3,717
Ala. 661 18 1,933 - 1 - 433 - 2 NN
Miss. 2,084 56 4,547 - 1 - 278 1 - NN
W.S. Central 4,124 355 16,275 15 2 - 3,500 27 17 16,159
Ark. 446 29 1,328 - - - 264 23 - NN
La. 1,608 87 5,422 2 - - 433 1 4 NN
Okla. 157 15 497 1 2 - 261 3 3 NN
Tex. 1,913 224 9,028 12 - - 2,542 - 10 16,159
Mountain 242 23 1,137 2 12 4 654 9 13 7,286
Mont. 3 - 9 - - - 24 3 - 53
Idaho 2 - 10 - 3 - 13 - - NN
Wyo. - - 3 - - 2 12 - - NN
Colo. 126 4 296 1 6 1 94 1 3 NN
N. Mex. 18 - 178 - - - 81 1 1 NN
Ariz. 50 16 419 - 1 - 249 - 4 6,783
Utah 12 - 51 1 2 - 55 2 2 450
Nev. 31 3 171 - - 1 126 2 3 NN
Pacific 872 197 7,765 6 54 16 5,628 8 133 1,224
Wash. 36 3 281 1 7 - 264 1 12 NN
Oreg. 22 - 100 - - - 165 4 5 NN
Calif. 807 194 7,321 5 43 12 4,859 2 111 NN
Alaska 3 - 22 - - 4 93 1 - NN
Hawaii 4 - 41 - 4 - 247 - 5 1,224
Guam 2 - 7 - - - 21 - 1 952
P.R. 311 20 2,018 2 - - 274 - - 9,193
V.I. 7 - 30 - - - 10 - - 551
C.N.M.I. - - - - - - 14 - 1 121





















*Cases updated through Division of Sexually Transmitted Diseases and HIV Prevention, National Center for Prevention Services,
as of February 28, 1995.
NOTIFIABLE DISEASES — Reported cases, by geographic division and area,
United States, 1994 (continued)























NAME Total Under 1  1-4 5-9 10-14 15-19 20-24 25-29 30-39 40-49 50-59 60 + stated
AIDS* 78,279 318 418 148 146 324 2,604 10,162 35,466 20,676 5,940 2,077 -
Amebiasis 2,983 19 116 178 144 102 142 208 474 243 123 122 1,112
Anthrax - - - - - - - - - - - - -
Aseptic meningitis 8,932 2,148 734 762 550 493 686 833 1,367 561 242 322 234
Botulism, total 143 81 2 - 3 2 6 8 8 14 10 5 4
Brucellosis 119 2 5 4 7 11 10 15 25 19 7 12 2
Cholera 39 - 1 - - 1 2 4 7 6 7 11 -
Diphtheria 2 - 1 - - - 1 - - - - - -
Encephalitis, primary infections 717 54 71 86 72 42 40 52 76 50 56 114 4
  Post-infectious 143 7 17 31 11 8 8 5 13 11 6 25 1
Escherichia coli  O157:H7 1,420 28 304 176 132 111 64 60 109 101 103 167 65
Gonorrhea† 413,647 - - - 8,508 123,079 121,084 60,204 63,985 ........................25,068 ................. 9,670
Haemophilus influenzae, invasive 1,174 210 119 33 18 26 18 23 74 76 79 463 35
Hansen disease (leprosy) 136 - - - 4 6 9 8 24 18 18 26 23
Hepatitis A 26,796 130 1,911 4,076 2,492 2,036 2,770 2,981 4,904 2,390 1,049 1,279 778
Hepatitis B 12,517 55 73 82 165 807 1,618 1,940 3,615 2,027 840 845 450
Hepatitis, C/non-A non-B 4,470 19 15 14 21 70 172 420 1,668 1,259 331 401 80
Hepatitis, unspecified 444 6 23 47 26 30 38 50 109 48 18 41 8
Legionellosis 1,615 6 5 4 3 19 28 39 170 259 276 768 38
Leptospirosis 38 - - 1 2 3 2 7 9 8 1 5 -
Lyme disease 13,043 27 650 1,142 831 632 473 640 2,062 2,207 1,612 2,540 227
Malaria 1,229 11 52 65 61 79 149 120 297 196 86 75 38
Measles (rubeola) 963 72 174 95 128 255 112 43 60 15 2 1 6
Meningococcal disease 2,886 479 537 248 183 332 180 87 157 162 122 333 66
Mumps 1,537 13 237 473 271 128 59 61 108 52 20 12 103
Pertussis (whooping cough) 4,617 1,640 837 496 548 301 66 76 187 129 46 34 257
Plague 17 - 2 2 2 1 - 1 2 3 3 - 1
Poliomyelitis, paralytic§ - - - - - - - - - - - - -
Psittacosis 38 - 1 - 2 - 1 3 10 15 3 3 -
Rabies, human 6 - - - 1 - 1 - - 4 - - -
Rheumatic fever, acute 112 1 4 28 26 10 3 4 8 3 - 4 21
Rocky Mountain spotted fever 465 3 29 51 24 34 23 25 85 58 61 65 7
Rubella (German measles) 227 11 17 13 4 11 32 33 54 38 10 4 -
Salmonellosis 43,323 5,265 6,425 2,804 1,600 1,541 2,011 2,261 4,406 2,879 1,975 4,511 7,645
Shigellosis 29,769 645 8,094 5,856 1,585 873 1,472 1,702 2,476 1,059 542 668 4,797
Syphilis, primary and secondary† 20,638 - - - 118 2,234 4,067 3,814 6,638 ..........................3,692 ................. 41
Tetanus 51 - - - 1 1 3 3 9 3 5 24 2
Toxic-shock syndrome 192 2 6 7 20 25 19 22 48 25 8 10 -
Trichinosis 32 - 1 1 2 3 6 1 8 2 4 4 -
Tuberculosis 24,361 164 860 399 272 544 1,281 1,808 4,859 4,375 2,920 6,831 48
Tularemia 96 1 7 11 8 4 5 3 3 12 16 22 4
Typhoid fever 441 10 43 51 32 38 59 49 90 28 19 16 6
Varicella (chickenpox) 151,219 227 2,772 4,119 771 256 207 218 219 78 33 37 142,282
NOTIFIABLE DISEASES — Summary of reported cases, by age group, United States, 1994
* AIDS total updated through December 31, 1994.
† Age data are collected on aggregate forms different from those used for numbers of reported cases. Therefore, total cases reported on this table may differ slightly from other tables.
Cases among persons ages <9 years are not shown because some of these may not be due to sexual transmission; however, they are included in the totals.






















American Indian Asian or Race not
Name Total or Alaskan Native Pacific Islander Black White Other stated
AIDS§ 78,279 227 576 31,457 33,180 - 12,839
Amebiasis 2,983 10 144 123 628 14 2,064
Anthrax - - - - - - -
Aseptic meningitis 8,932 19 155 1,338 5,229 23 2,168
Botulism, total 143 11 4 1 97 1 29
Brucellosis 119 - - 5 64 3 47
Cholera 39 - 2 - 17 1 19
Diphtheria 2 - - - 2 - -
Encephalitis, primary infections 717 1 11 80 484 3 138
  Post-infectious 143 - 2 20 96 - 25
Escherichia coli  O157:H7 1,420 3 9 31 856 6 515
Gonorrhea¶ 413,647 1,829 1,416 271,195 43,618 - 95,589
Haemophilus influenzae, invasive 1,174 16 13 174 701 1 269
Hansen disease (leprosy) 136 - 57 3 29 - 47
Hepatitis A 26,796 2,330 386 1,737 15,275 98 6,970
Hepatitis B 12,517 101 837 2,745 5,158 50 3,626
Hepatitis, C/non-A non-B 4,470 53 35 723 2,400 9 1,250
Hepatitis, unspecified 444 22 14 33 242 1 132
Legionellosis 1,615 7 14 138 999 1 456
Leptospirosis 38 - 8 - 23 - 7
Lyme disease 13,043 41 82 205 9,589 7 3,119
Malaria 1,229 3 167 407 327 22 303
Measles (rubeola) 963 1 37 80 641 - 204
Meningococcal disease 2,886 34 32 352 1,869 8 591
Mumps 1,537 8 55 115 887 1 471
Pertussis (whooping cough) 4,617 20 57 281 2,454 9 1,796
Plague 17 8 - - 7 - 2
Poliomyelitis, paralytic** - - - - - - -
Psittacosis 38 1 - - 19 - 18
Rabies, human 6 - - 1 4 - 1
Rheumatic fever, acute 112 1 2 1 58 - 50
Rocky Mountain spotted fever 465 14 2 19 324 1 105
Rubella (German measles) 227 - 12 9 131 48 27
Rubella, congenital syndrome 7 - 1 1 5 - -
Salmonellosis 43,323 264 512 3,713 19,702 49 19,083
Shigellosis 29,769 731 161 5,169 12,159 34 11,515
Syphilis, primary and secondary¶ 20,638 43 73 17,619 1,830 - 1,073
Tetanus 51 - 1 9 32 - 9
Toxic-shock syndrome 192 - 5 4 145 - 38
Trichinosis 32 - 1 2 12 - 17
Tuberculosis 24,361 341 3,868 8,622 11,309 - 221
Tularemia 96 2 1 2 69 - 22
Typhoid fever 441 5 126 44 73 12 181
Varicella (chickenpox) 151,219 6 232 1,997 853 - 148,131
NOTIFIABLE DISEASES — Summary of reported cases, by race,* United States, 1994
 *Some information on race/ethnicity was reported using one variable with the following categories: American Indian or Alaska Native, Asian or Pacific Islander, Black non-Hispanic,
White non-Hispanic, and Hispanic. Race not stated includes cases originally reported as Hispanic. 
† Includes cases originally reported as Hispanic: 12,699 for AIDS; 14,907 for Gonorrhea; and 794 for Syphilis, primary and secondary.
§AIDS total reported through December 31, 1994.
¶Race data are collected on aggregate forms different from those used for numbers of reported cases. Therefore, total cases reported on this table may differ slightly from other
tables.























NAME Total Hispanic Non-Hispanic stated
AIDS† 78,279 12,699 64,637 943
Amebiasis 2,983 386 541 2,056
Anthrax - - - -
Aseptic meningitis 8,932 1,030 4,369 3,533
Botulism, total 135 26 73 36
Brucellosis 119 79 15 25
Cholera 39 17 10 12
Diphtheria 2 - 2 -
Encephalitis, primary infections 717 42 343 332
  Post-infectious 143 12 75 56
Escherichia coli  O157:H7 1,420 34 708 678
Gonorrhea§ 413,647 14,907 314,813 83,927
Haemophilus influenzae, invasive 1,174 66 712 396
Hansen disease (leprosy) 136 30 70 36
Hepatitis A 26,796 5,386 13,940 7,470
Hepatitis B 12,517 1,031 6,580 4,906
Hepatitis, C/non-A non-B 4,470 387 2,259 1,824
Hepatitis, unspecified 444 123 214 107
Legionellosis 1,615 26 823 766
Leptospirosis 38 - 20 18
Lyme disease 13,043 165 6,118 6,760
Malaria 1,229 91 716 422
Measles (rubeola) 963 55 651 257
Meningococcal disease 2,886 298 1,684 904
Mumps 1,537 188 684 665
Pertussis (whooping cough) 4,617 403 2,050 2,164
Plague 17 - 16 1
Poliomyelitis, paralytic¶ - - - -
Psittacosis 38 2 12 24
Rabies, human 6 1 2 3
Rheumatic fever, acute 112 5 28 79
Rocky Mountain spotted fever 465 6 244 215
Rubella (German measles) 227 78 118 31
Rubella, congenital syndrome 7 3 4 -
Salmonellosis 43,323 2,564 16,052 24,707
Shigellosis 29,769 2,909 12,149 14,711
Syphilis, primary and secondary§ 20,638 794 19,449 395
Tetanus 51 1 28 22
Toxic-shock syndrome 192 5 127 60
Trichinosis 32 1 7 24
Tuberculosis 24,361 5,074 19,084 203
Tularemia 96 2 22 72
Typhoid fever 441 114 204 123
Varicella (chickenpox) 151,219 1,697 1,393 148,129
NOTIFIABLE DISEASES — Summary of reported cases, by ethnicity,* United States, 1994
 *Some information on race/ethnicity was reported using one variable with the following categories: American Indian or Alaska
Native, Asian or Pacific Islander, Black non-Hispanic, White non-Hispanic, and Hispanic. Ethnicity not stated includes cases
originally reported as American Indian or Alaska Native and Asian or Pacific Islander.
 † AIDS total reported through December 31, 1994.
 §Ethnicity data are collected on aggregate forms different from those used for numbers of reported cases. Therefore, total cases
reported on this table may differ slightly from other tables.























*Includes Guam, Puerto Rico, the U.S. Pacific Islands, and the U.S. Virgin Islands.
•The expanded AIDS surveillance case definition implemented January 1, 1993 includes conditions that occur earlier in HIV disease. Persons diagnosed with
these conditions before January 1993 were reported to CDC during 1993 and 1994, accounting for the substantial increase in the number of reported cases.

















*The denominator for Puerto Rico is based on extrapolations from U.S. Bureau of Census population data from 1990 and 1992 post-censal estimates.
• In 1994, 84% of reported cases of AIDS were among residents of large metropolitan areas (500,000 or more population).
≥

















*Children <13 years of age.
•AIDS cases reported among children ages <13 years during 1994 (1,017) were 8% greater than that reported during 1993 (942). Of the 1,017 children affected,
62% were black, 23% were Hispanic, and 50% were female.
≥
















•California serogroup viruses consistently produce primarily pediatric clinical encephalitis cases in various areas of the eastern United States.
ARBOVIRAL INFECTIONS (of the central nervous system) — reported laboratory-confirmed cases caused by California
















•Human eastern equine encephalitis cases, often associated with high mortality rates (20%) and severe neurologic sequelae, occur in low frequency in states
along the Atlantic coast.
ARBOVIRAL INFECTIONS (of the central nervous system) — reported laboratory-confirmed cases caused by eastern equine
















•St. Louis encephalitis, which has historically produced large epidemics, frequently causes intense local outbreaks (e.g., New Orleans, 1994).
ARBOVIRAL INFECTIONS (of the central nervous system) — reported laboratory-confirmed cases caused by St. Louis
















•Human western equine encephalitis cases, for unclear reasons, have occurred only sporadically since the outbreaks in 1987.
ARBOVIRAL INFECTIONS (of the central nervous system) — reported laboratory-confirmed cases caused by western equine















*Data not yet available for 1994.
•Although cases of foodborne botulism remain uncommon, outbreaks (including restaurant-associated ones) continue to occur and, because of the severity
of the illness, constitute public health emergencies.
















*Data not yet available for 1994.
• Infant botulism was first recognized in 1975 and is now diagnosed in 70–100 infants annually.















•Recent data suggest that reported cases of foodborne brucellosis, usually caused by Brucella melitensis, are increasing in the United States.
















• In recent years, most U.S. cholera cases have been associated with foreign travel or food brought into the country from cholera-affected areas. Previously,
cholera was more often acquired domestically from shellfish harvested in the Gulf of Mexico.















NOTE: DTP vaccine licensed 1949.
•An ongoing epidemic of diphtheria is occurring in 14 of the 15 countries of the former Soviet Union. Two cases were reported among U.S. citizens residing
in the former Soviet Union. No importation of diphtheria into the United States related to these outbreaks was reported in 1994.
















•States in which E. coli  O157:H7 infection is a notifiable disease increased from nine in 1992 to 33 in 1994. However, because fewer than 60% of clinical
laboratories routinely test all stools or all bloody stools for E. coli  O157:H7, many infections are not recognized or reported.
≥















*Data from the Public Health Laboratory Information System (PHLIS).
•From 1993 to 1994, the number of states reporting E. coli  O157:H7 isolates to the PHLIS increased more than threefold. Identification of E. coli  O157:H7
must be confirmed by the state public health laboratory to be reported to PHLIS.
≥















S• In 1994, the rate of gonorrhea among men continued to decline; among women it increased from 147.1 per 100,000 in 1993 to 153.7.















• In 1994, gonorrhea rates increased slightly among all racial and ethnic groups except Hispanics.
















NOTE: The Year 2000 Objective is ≤225 per 100,000 population.
•The overall U.S. gonorrhea rate in 1994 was 168.4 per 100,000 and 37 states reported rates below the Healthy People 2000 national objective.















• Invasive H. influenzae  disease was reported in 329 children ages <5 years. Of 52 cases with known serotype, 31 were reported as serotype B. Lack of
information on serotype prevented accurately determining whether most of the cases were vaccine-preventable or represented vaccine failures.















S•During the past 30 years in the United States, new Hansen disease cases have continued to occur at a fairly constant rate, except for the increase related
to foreign immigration between 1978–1988.















* The first hepatitis B vaccine was licensed June 1982.
†
Anti-HCV antibody test available May 1990.
•Non-A, non-B hepatitis reporting was artificially increased after introduction of the anti-hepatitis C virus antibody test in 1990, and has since declined.
†
















•Although the western states have overall higher incidence rates of hepatitis A, high-rate cities and counties in the remaining states also account for substantial
reports. Such cases are often reported in connection with communitywide outbreaks.
≥















•Hepatitis B continues to decline in most states, primarily because of changes in high-risk behaviors among injecting-drug users. High incidence rates are
often associated with cities and counties with large urban populations.
≥
















•The increase in annual legionellosis rates during recent years is likely associated with greater availability and use of new diagnostic tests, including urinary
antigen assays, for evidence of infection.















•The number of reported Lyme disease cases increased 58% from 1993 to 1994, coincident with increases in the density of vector tick populations in several
northeastern states where Lyme disease is endemic.
≥
















• In 1994, Plasmodium vivax  infection was diagnosed in three persons in Houston, Texas. These persons did not have recent bloodborne exposure and had
not recently travelled to areas where malaria is endemic, strongly suggesting mosquito-borne transmission of malaria in the United States.
















• In 1994, 963 cases of measles were reported—the second lowest annual total ever. The largest outbreaks were reported among communities that do not
accept vaccination.
















•Although overall rates of meningococcal disease have remained relatively constant, serogroup C outbreaks are occurring more frequently in the United
States, and vaccine use for outbreak control has increased. In addition, Oregon and part of Washington state reported a substantial increase of serogroup
B disease in 1994. The meningococcal vaccine licensed in the United States provides protection against serogroups A, C, Y, and W-135, but not against
serogroup B.
















NOTE: Mumps vaccine licensed December 1967.
• In 1994, 1,537 mumps cases were reported—the lowest number ever reported in the United States.
















NOTE: DTP vaccine licensed 1949.
•The number of reported pertussis cases declined 30% from 1993–1994—a pattern consistent with the previously observed 3–4 year periodicity in pertussis
incidence.
















•Of 734 pertussis cases among children 7 months to 4 years of age with known vaccination status, 320 (43.6%) had received fewer than three doses of
diphtheria-tetanus-pertussis vaccine—the minimum number of doses necessary for clinical protection.















S•Plague continued to be enzootic throughout the 14 contiguous western states, resulting in sporadic human cases caused primarily by the bites of infected
rodent fleas, but also by direct contact with infected animals.
















NOTE: Inactivated vaccine licensed 1955. Oral vaccine licensed 1961.
•Since 1980, all confirmed cases of indigenously acquired paralytic poliomyelitis in the United States have been vaccine-associated.
















•The decline of psittacosis cases reported during recent years may reflect a return to baseline incidence, as cases of Chlamydia pneumoniae  may have been
attributed to Chlamydia psittaci  infection in the mid-1980’s.
















•The number of humans administered rabies post-exposure treatment continues to increase as animal rabies cases increase, especially in the northeastern
United States where raccoon rabies continues to spread.
















•RMSF is the most common fatal tick-borne disease in the United States, with a case fatality rate of 2%.
















• In 1994, 227 cases of rubella were reported in the United States. Of these cases 171 (75%) occurred among persons ages ≥20 years, and 126 (56%) were
reported from one state. Of seven cases of congenital rubella syndrome reported, four were caused by international importation and three were acquired
in the United States.






























*Data from Public Health Laboratory Information System.
• In 1994, an outbreak of Salmonella  serotype Enteritidis infection was linked to a nationally distributed ice cream brand. Illnesses were documented in
41 states, and more than 200,000 persons were estimated to have been ill.






























*Data from Public Health Laboratory Information System.
•Community outbreaks of Shigella sonnei, often involving multiple child care centers, continue to be a substantial public health problem.
















NOTE: The Year 2000 Objective is ≤10.0 per 100,000 population.
• In 1994, the rate of primary and secondary syphilis was 8.1 per 100,000. Rates were below the Healthy People 2000 national objective in 38 states, with 10
states reporting fewer than five cases.
















• In 1994, the rate of primary and secondary syphilis among men decreased from 11.3 per 100,000 in 1993 to 8.6, and from 9.5 to 7.6 among women.
















•Since 1990, the rates of primary and secondary syphilis have declined among all racial and ethnic groups. However, the 1994 rate of 59.5 cases per 100,000
for non-Hispanic blacks was 60 times greater than for non-Hispanic whites.
















*The surveillance case definition for congenital syphilis changed in 1989.
•Between 1993 and 1994, the rate of congenital syphilis decreased from 80.7 to 55.6 cases per 100,000 live births.
















NOTE: Tetanus toxoid was first available in 1933.
•The 1996 goal for tetanus disease reduction in the United States is zero cases among children ages <15 years; in 1994, one tetanus case was reported in a
child 12 years of age.
















*Includes only cases that meet the CDC case definition for staphylococcal  TSS.
†
First available through NETSS beginning 1983.
•The number of reported cases of TSS continued a downward trend. In 1994, 42% (10) of confirmed TSS cases were nonmenstrual.
†














• In 1994, 32 cases were reported, below the mean number reported for the years 1990–1994.
















•Fifteen states have tuberculosis rates ≤3.5 cases per 100,000, the interim tuberculosis elimination goal for the year 2000.
≥
















• In 1994, 24,361 cases of tuberculosis (9.4 per 100,000) were reported to CDC from the United States, representing a 3.7% decrease from 1993.
















•The number and percent of tuberculosis cases among the foreign-born has increased from 4,925 (21.6%) in 1986 to 7,627 (31.3%) in 1994.
















•A new single dose parenteral typhoid vaccine was licensed for use in the United States in 1994. The new vaccine is an alternative to the four-dose oral
vaccine available.
















*Varicella is reportable in 25 states.
•Approximately 3.7 million cases of varicella occur annually in the United States; of these, an estimated 4%–5% are reported.































 Disease 1994 1993 1992 1991 1990 1989 1988 1987 1986 1985
AIDS 30.07 40.20 17.83 17.32  16.72  13.58  12.61  8.66  5.36  3.46
Amebiasis 1.20 1.21  1.21 1.23  1.38  1.34  1.20  1.33  1.47 1.92
Anthrax 0.00 0.00 0.00 0.00  0.00  0.00  0.00  0.00  0.00  0.00
Aseptic meningitis 3.71 5.39 5.18 6.26  4.77  4.14  2.94  4.72  4.72  4.50
Botulism, total (including wound and unsp.) 0.06 0.04 0.04 0.05 0.04 0.04 0.03  0.03  0.05  0.05
 Foodborne 0.02 0.01 0.00 0.01  0.01  0.01  0.01  0.01  0.01  0.02
Brucellosis 0.05 0.05 0.04 0.04  0.03  0.04  0.04  0.05  0.04  0.06
Chancroid* 0.30 0.54 0.80 1.40  1.70  1.90  2.04  2.07  1.57  0.87
Cholera 0.02 0.00 0.04  0.01  0.00  0.00  0.00  0.00  0.01  0.00
Diphtheria 0.00 0.00 0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00
Encephalitis, primary 0.28 0.36 0.30  0.40  0.54  0.40  0.36  0.58  0.54  0.58
 Post-infectious 0.06 0.07 0.05  0.03  0.04  0.04  0.05  0.05  0.05  0.07
Escherichia coli  O157:H7 0.82.....................................................................................................  † ................................................................................................
Gonorrhea* 168.40 172.40 201.60 249.48 276.60  297.36  298.74  323.14  376.37 384.51
Granuloma inguinale* 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.01 0.03 0.02
Haemophilus influenzae, invasive 0.45 0.55 0.55 1.10 ........................................................... †........................................................................
Hansen disease (leprosy) 0.05 0.07 0.07  0.06 0.08  0.07  0.07  0.10  0.11  0.15
Hepatitis A 10.29 9.40 9.06 9.67  12.64  14.43  11.60  10.39  10.02  10.03
Hepatitis B 4.81 5.18 6.32  7.14  8.48  9.43  9.43  10.65  11.17  11.50
Hepatitis, C/non-A, non-B§ 1.78 1.86 2.36  1.42 1.03  1.02  1.07  1.23  1.55  l.81
Hepatitis, unspecified 0.17 0.24 0.35  0.50 0.67  0.93  1.00  1.27  1.69  2.38
Legionellosis 0.63 0.50 0.53  0.53 0.55  0.48  0.44  0.43  0.43  0.37
Leptospirosis 0.02 0.02 0.02  0.02 0.03  0.04  0.02  0.02  0.02  0.02
Lyme disease 5.01 3.20  0.12 3.80 ............................................................ †.......................................................................
Lymphogranuloma venereum* 0.10 0.10  0.10  0.19 0.10  0.08  0.07  0.13  0.16  0.10
Malaria 0.47 0.55  0.43  0.51  0.52  0.51  0.45  0.39  0.47  0.44
Measles (rubeola) 0.37 0.12 0.88 3.82  11.17  7.33  1.38  1.50  2.61  1.18
Meningococcal disease 1.11 1.02  0.84  0.84 0.99  1.10  1.21  1.20  1.08  1.04
Mumps 0.60 0.66  1.03 1.72  2.17  2.34  2.05  5.43  3.37  1.30
Murine typhus fever    ¶ 0.01  0.01  0.02  0.02  0.02  0.02  0.02  0.03  0.02
Pertussis (whooping cough) 1.77 2.55  1.60  1.08  1.84  1.67  1.40  1.16  1.74  1.50
Plague 0.01 0.00  0.01  0.00  0.00  0.00  0.01  0.00  0.00  0.01
Poliomyelitis, paralytic 0.00 0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00
Psittacosis 0.02 0.02  0.04 0.04  0.05  0.05  0.05  0.04  0.09  0.05
Rabies, human 0.00 0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00
Rheumatic fever, acute 0.09 0.08  0.06  0.12  0.09  0.13  0.14  0.13  0.12  0.07
Rocky Mountain spotted fever 0.18 0.18  0.20  0.25  0.26  0.25  0.25  0.25  0.32  0.30
Rubella (German measles) 0.09 0.07  0.06 0.56  0.45 0.16  0.09  0.13  0.23  0.26
Salmonellosis, excluding typhoid fever 16.64 16.15 16.04 19.10  19.54  19.26  19.91  20.92  20.73  27.37
Shigellosis 11.44 12.48 9.38 9.34  10.89  10.07  12.46  9.80  7.11  7.14
Smallpox .....................................................................................Last documented case occurred in 1949......................................................................
Syphilis, primary and secondary* 8.10 10.40 13.70 17.26 20.10  18.07  16.43  14.54  11.65  11.45
 Total, all stages* 32.00 39.70 45.30  51.69 53.80  44.94  42.37  35.81  28.50  28.50
Tetanus 0.02 0.02  0.02 0.02  0.03  0.02  0.02  0.02  0.03  0.03
Toxic-shock syndrome 0.10 0.08  0.10  0.11  0.13  0.16  0.16  0.15  0.19  0.18
Trichinosis 0.01 0.01  0.02 0.02  0.05  0.01  0.02  0.02  0.02  0.03
Tuberculosis 9.36 9.82 10.46 10.42  10.33  9.46  9.13  9.25  9.44  9.30
Tularemia 0.04 0.05  0.06  0.08  0.06  0.06  0.08  0.09  0.07  0.07
Typhoid fever 0.17  0.17  0.16 0.20  0.22  0.19  0.18  0.16  0.15  0.17
Varicella (chickenpox) 135.76 118.54 176.54 135.82 120.06 121.77  122.43  136.68  122.42 123.23
Yellow fever ......................................................................Last indigenous case reported 1911; last imported, 1924.......................................................
TABLE 1. NOTIFIABLE DISEASES — summary of reported cases, per 100,000 population, United States, 1985–1994
NOTE: Rates <0.01 after rounding are shown as 0.00.
*Post-censal population data from 1993 were used to calculate 1994 rates.
†
Not previously nationally notifiable.
§
Anti-HCV antibody test available May 1990.
¶

























 Disease 1994 1993 1992 1991 1990 1989 1988 1987 1986 1985
AIDS 78,279 103,533 45,472 43,672 41,595 33,722 31,001 21,070 12,932 8,249
Amebiasis 2,983 2,970 2,942 2,989 3,328 3,217 2,860 3,123 3,532 4,433
Anthrax - - 1 – – – 2 1 – –
Aseptic meningitis 8,932 12,848 12,223 14,526 11,852 10,274 7,234 11,487 11,374 10,619
Botulism, total (including wound and unsp.) 143 97 91 114 92 89 84 82 109 122
 Foodborne 50 27 21 27 23 23 28 17 23 49
 Infant 85 65 66 81 65 60 50 59 79 70
Brucellosis 119 120 105 104 85 95 96 129 106 153
Chancroid 773 1,399 1,886 3,476 4,212 4,692 5,001 4,998 3,756 2,067
Cholera 39 18 103 26 6 – 8 6 23 4
Diphtheria 2 - 4 5 4 3 2 3 – 3
Encephalitis, primary 717 919 774 1,021 1,341 981 882 1,418 1,302 1,376
 Post-infectious 143 170 129 82 105 88 121 121 124 161
Escherichia coli  O157:H7 1,420........................................................................................... *.............................................................................
Gonorrhea 418,068 439,673 501,409  620,478 690,169 733,151 719,536 780,905 900,868 911,419
Granuloma inguinale 3 19 6 29 97 7 11 22 61 44
Haemophilus influenzae, invasive 1,174 1,419 1,412 2,764 .....................................................* ..........................................................
Hansen disease (leprosy) 136 187 172 154 198 163 184 238 270 361
Hepatitis A 29,796 24,238 23,112 24,378 31,441 35,821 28,507 25,280  23,430
†
   23,210
†
Hepatitis B 12,517  13,361 16,126  18,003 21,102  23,419  23,177  25,916  26,107
†





4,470 4,786 6,010 3,582 2,553 2,529 2,619 2,999 3,634
†
     4,184
†
Hepatitis, unspecified 444 627 884 1,260 1,671 2,306 2,470 3,102 3,940
†
    5,517
†
Legionellosis 1,615 1,280 1,339 1,317 1,370 1,190 1,085 1,038 948 830
Leptospirosis 38 51 54 58 77 93 54 43 41 57
Lyme disease 13,043 8,257 9,895 9,465 .....................................................* ..........................................................
Lymphogranuloma venereum 235 285 302 471 277 189 185 303 396 226
Malaria 1,229 1,411 1,087 1,278 1,292 1,277 1,099 944 1,123 1,049
Measles (rubeola) 963 312 2,237 9,643 27,786 18,193 3,396 3,655 6,282 2,822
Meningococcal disease 2,886 2,637 2,134 2,130 2,451 2,727 2,964 2,930 2,594 2,479
Mumps 1,537 1,692 2,572 4,264 5,292 5,712 4,866 12,848 7,790 2,982
Murine typhus fever ¶ 25 28 43 50 41 54 49 67 37

























Pertussis (whooping cough) 4,617 6,586 4,083 2,719 4,570 4,157 3,450 2,823 4,195 3,589
Plague 17 10 13 11 2 4 15 12 10 17
Poliomyelitis, paralytic** - 3 6 9 6 9 9 9 9 7
Psittacosis 38 60 92 94 113 116 114 98 224 119
Rabies, animal 8,147 9,377 8,589 6,910 4,826 4,724 4,651 4,658 5,504 5,565
Rabies, human 6 3 1 3 1 1 – 1 – 1
Rheumatic fever, acute 112 112 75 127 108 144 158 141 147 90
Rocky Mountain spotted fever 465 456 502  628 651 623 609 604 760 714
Rubella (German measles) 227 192  160 1,401 1,125 396 225 306 551 630
Rubella, congenital syndrome 7 5 11 47 11 3 6 5 14 –
Salmonellosis, excluding typhoid fever 43,323 41,641 40,912 48,154 48,603 47,812 48,948 50,916 49,984 65,347
Shigellosis 29,769 32,198 23,931 23,548 27,077 25,010 30,617 23,860 17,138 17,057
Smallpox ................................................. Last documented case occurred in 1949.....................................................
Syphilis, primary and secondary 20,627 26,498 33,973 42,935 50,223 44,540 40,117 35,147 27,883 27,131
 Total, all stages 81,696 101,259 112,581 128,569 134,255 110,797 103,437  86,545  68,215  67,563 
Tetanus 51 48 45 57 64 53 53 48 64 83
Toxic–shock syndrome 192 212 244 280 322 400 390 372 412 384
Trichinosis 32 16  41 62 129 30 45 40 39 61
Tuberculosis 24,361 25,313 26,673 26,283 25,701 23,495 22,436 22,517 22,768 22,201
Tularemia 96 132 159 193 152 152 201 214 170 177
Typhoid fever 441 440 414 501 552 460 436 400 362 402
Varicella (chickenpox) 151,219 134,722 158,364 147,076 173,099 185,441 192,857 213,196 183,243 178,162
Yellow fever ........................................................................................................Last indigenous case reported 1911; last imported, 1924 ..........................................
........... .
 * Not previously nationally notifiable.
†
Reports from New York City are not available.
§
Anti-HCV antibody test available May 1990.
¶
No longer nationally notifiable.
** Annual case reports from state health departments; numbers may not reflect changes based on retrospective case evaluations or late reports (see



























Disease 1984 1983 1982 1981 1980 1979 1978 1977 1976 1975
AIDS 4,445 ............................................................................................... * ........................................................................................................
Amebiasis 5,252 6,658 7,304 6,632  5,271  4,107  3,937  3,044  2,906  2,775
Anthrax 1 –  – –  1  –  6  –  2  2
Aseptic meningitis 8,326 12,696 9,680 9,547  8,028  8,754  6,573  4,789  3,510  4,475
Botulism, total (including wound and unsp.) 123 133  97 103  89  45  105  129  55  20
Brucellosis 131  200  173 185  183  215  179  232  296  310
Chancroid 665 847  1,392 850  788  840  521  455  628  700
Cholera 1 1  – 19  9  1  12  3  –  –
Diphtheria 1 5  2 5  3  59  76  84  128  307
Encephalitis, primary
†
1,257 1,761  1,464 1,492  1,362  1,504  1,351  1,414  1,651  4,064
 Post-infectious
†
 108 34 36 43  40  84  78  119  175  237
Gonorrhea 878,556 900,435 960,633 990,864 1,004,029 1,004,058 1,013,436 1,002,219 1,001,994 999,937
Granuloma inguinale 30 24  17 66  51  76  72  75  71  60
Hansen disease (leprosy) 290 259  250 256  223  185  168  151  145  162 
Hepatitis A 22,040 21,532 23,403 25,802  29,087  30,407  29,500  31,153  33,288  35,855
Hepatitis B  26,115 24,318  22,177 21,152  19,015  15,452  15,016  16,831  14,973  13,121
Hepatitis, non-A, non-B 3,871 3,470 ........................................................................................... * ................................................................................................
Hepatitis, unspecified 5,531 7,149 8,564 10,975  11,894  10,534  8,776  8,639  7,488  7,158
Legionellosis
§
750 852  654 408  475  593  761  359  235 *
Leptospirosis 40 61  100 82  85  94  110  71  73 93
Lymphogranuloma venereum 170 335  235 263  199  250  284  348  365  353
Malaria 1,007 813  1,056 1,388  2,062  894  731  547  471  373
Measles (rubeola) 2,587 1,497  1,714 3,124  13,506  13,597  26,871  57,345  41,126  24,374
Meningococcal disease 2,746 2,736  3,056 3,525  2,840  2,724  2,505  1,828  1,605  1,478
Mumps 3,021 3,355  5,270 4,941  8,576  14,225  16,817  21,436  38,492  59,647
Murine typhus fever 53 62  58 61  81  69  46  75  69  41



























Pertussis (whooping cough) 2,276 2,463  1,895 1,248  1,730  1,623  2,063  2,177  1,010  1,738
Plague 31 40  19 13  18  13  12  18  16  20
Poliomyelitis, total 8 15  8 6  9  34  15  18  14  8
 Paralytic 8 15  8 6  8  26  9  17  12  8
Psittacosis 172 142  152 136  124  137  140  94  78  49
Rabies, animal 5,567 5,878  6,212 7,118  6,421  5,119  3,254  3,130  3,073  2,627
Rabies, human 3 2  – 2 –  4  4  1  2 2 
Rheumatic fever, acute 117 88  137 264  432  629  851  1,738  1,865  2,854
Rocky Mountain spotted fever 838 1,126  976 1,192  1,163  1,070  1,063  1,153  937  844
Rubella (German measles) 752 970  2,325 2,077  3,904  11,795  18,269  20,395  12,491  16,652
Rubella, congenital syndrome 5 22  7 19  50  62  30  23  30  30
Salmonellosis, excluding typhoid fever 40,861 44,250 40,936  39,990  33,715  33,138  29,410  27,850  22,937  22,612
Shigellosis 17,371 19,719 18,129 19,859  19,041  20,135  19,511  16,052  13,140  16,584
Smallpox ................................................................................ Last documented case occurred in 1949 ..........................................................................
Syphilis, primary and secondary 28,607 32,698  33,613 31,266  27,204  24,874  21,656  20,399  23,731  25,561
 Total, all stages 69,888 74,637 75,579 72,799  68,832  67,049  64,875  64,621  71,761  80,356
Tetanus 74 91  88 72  95  81  86  87  75  102
Toxic-shock syndrome 482 502 ........................................................................................... * ................................................................................................
Trichinosis 68 45  115 206  131  157  67  143  115  252
Tuberculosis 22,255 23,846 25,520 27,373  27,749  27,669  28,521  30,145  32,105  33,989
Tularemia 291 310  275 288  234  196  141  165  157  129
Typhoid fever 390 507  425 584  510  528  505  398  419  375 
Varicella (chickenpox) 221,983 177,462 167,423 200,766 190,894 199,081 154,089 188,396 183,990  154,248
Yellow fever ...................................................................... Last indigenous case reported 1911, last imported 1924 .......................................................
*Not previously notifiable nationally.
†
Beginning in 1984, data reflects change in categories for tabulating encephalitis reports that were recorded by date of report to state health departments.
Data for previous years are from surveillance records reported by onset date.
§



























 Disease 1974 1973 1972 1971 1970 1969 1968 1967 1966 1965
Amebiasis 2,743 2,235  2,199 2,752  2,888  2,915  3,005  3,157  2,921  2,768 
Anthrax 2 2  2 5  2  4  3  2  5  7 
Aseptic meningitis 3,197 4,846  4,634 5,176  6,480  3,672  4,494  3,082  3,058  2,329 
Botulism 28 34  22 25  12  16  7  5  9  19 
Brucellosis 240 202  196 183  213  235  218  265  262  262 
Chancroid 945 1,165  1,414 1,320  1,416  1,104  845  784  838  982 
Cholera – 1  – 1  –  –  –  –  –  2 
Diphtheria 272 228  152 215  435  241  260  219  209  164 
Encephalitis, primary 1,164 1,613  1,059 1,524  1,580  1,613  1,781  1,478  2,121  1,722 
 Post-infectious 218 354  243 439  370  304  502  1,060  964  981 
Gonorrhea 906,121 842,621 767,215 670,268 600,072 534,872 464,543 404,836 351,738 324,925 
Granuloma inguinale 47 62  81 89  124  154  156  154  148 155 
Hansen disease (leprosy) 118 146  130 131  129  98  123  81  109 96 
Hepatitis A (infectious) 40,358 50,749 54,074 59,606 56,797 48,416 45,893 38,909 32,859 33,856*
Hepatitis B (serum) 10,631 8,451  9,402 9,556 8,310 5,909 4,829 2,458 1,497
Hepatitis, unspecified 8,351 .................................................................................................................† ..................................................................................................
Leptospirosis 68 57  41 62  47  89  69  67  72  84  
Lymphogranuloma venereum 394 408  756 692  612  520  485  371  308  878 
Malaria 293 237  742 2,375  3,051  3,102  2,317  2,022  565  147 
Measles (rubeola) 22,094 26,690  32,275 75,290  47,351  25,826  22,231  62,705 204,136 261,904 
Meningococcal disease 1,346 1,378  1,323 2,262  2,505  2,951  2,623  2,161  3,381  3,040 
Mumps 59,128 69,612 74,215 124,939 104,953 90,918 152,209................................... † ................................
Murine typhus fever 26 32  18 23  27  36  36  52  33  28 



























Pertussis (whooping cough) 2,402 1,759  3,287 3,036  4,249  3,285  4,810  9,718  7,717  6,799 
Plague 8 2  1 2  13  5  3  3  5  8 
Poliomyelitis, total 7 8  31 21  33  20  53  41  113  72 
 Paralytic 7 7  29 17  31  18  53  40  106  61 
Psittacosis 164 33  52 32  35  57  43  41  50  60 
Rabies, animal 3,151 3,640  4,369 4,310  3,224  3,490  3,591  4,481  4,178  4,574 
Rabies, human – 1  2 2  3  1  1  2  1  2 
Rheumatic fever, acute 2,431 2,560 2,614  2,793  3,227  3,229  3,470  3,985  4,472  4,998 
Rocky Mountain spotted fever 754 668  523 432  380  498  298  305  268  281 
Rubella (German measles) 11,917 27,804  25,507 45,086  56,552  57,686  49,371  46,888  46,975  †
Rubella, congenital syndrome 45 35  42 68  77  31  14  10  11  †
Salmonellosis, excluding typhoid fever 21,980 23,818  22,151 21,928  22,096  18,419  16,514  18,120  16,841  17,161 
Shigellosis 22,600 22,642  20,207 16,143  13,845  11,946  12,180  13,474  11,888  11,027 
Smallpox  ....................................................................................  Last documented case occurred in 1949 .....................................................................
Streptococcal sore throat and scarlet fever NN NN NN NN 433,405 450,008 435,013 453,351 427,752 395,168 
Syphilis, primary and secondary 25,385 24,825  24,429 23,783  21,982  19,130  19,019  21,053  21,414  23,338 
 Total, all stages 83,771 87,469  91,149 95,997  91,382  92,162  96,271 102,581 105,159 112,842 
Tetanus 101 101  128 116  148  192  178  263  235  300 
Trichinosis 120 102  89 103  109  215  77  66  115  199 
Tuberculosis
§
30,122 30,998  32,882 35,217  37,137  39,120  42,623  45,647  47,767  49,016 
Tularemia 144 171  152 187  172  149  186  184  208  264 
Typhoid fever 437 680  398 407  346  364  395  396  378  454 
Varicella (chickenpox) 141,495 182,927 164,114 ........................................................................................† ............................................................................
Yellow fever . .....................................................................Last indigenous case reported 1911; last imported, 1924.......................................................
*Includes serum hepatitis.
†
Not previously notifiable nationally.
§



























Disease 1964 1963 1962 1961 1960 1959 1958 1957 1956 1955
Amebiasis 3,304 2,886 3,048  2,850  3,424  3,508  4,380  5,031  3,689  3,348 
Anthrax 5 3 9  14  23  12  16  26  38  39
Aseptic meningitis 2,177 1,844  2,654  5,162*  1,593.................................................................† .....................................................
Botulism 23 47 10  14  12  20  6  28  17  16
Brucellosis 411 407 409  636  751  892  924  983  1,300  1,444
Chancroid 1,247 1,220  1,344  1,438  1,680  1,537  1,595  1,637  2,135  2,649
Cholera – –  –  –  –  –  –  –  –  –
Dengue NN NN NN  –  –  –  –  –  2  1
Diphtheria 293 314  444  617  918  934  918  1,211  1,568  1,984
Encephalitis, acute infectious (primary) 2,002 1,993  2,094  2,248  2,341  2,437  2,587  2,135  2,624  2,166
 Post-infectious 1,585 .............................................................................................................† .........................................................................................................
Gonorrhea 300,666 278,289 263,714 264,158 258,933 240,254 232,386 214,496 224,346 236,197
Granuloma inguinale 135 173  207  241  296  265  314  348  357  490
Hansen disease (leprosy) 97 103  80  63 54  44  39  36  52  75
Hepatitis
§
37,740 42,974 53,016  72,651  41,666  23,574  16,294  14,922  19,234  31,961
Leptospirosis 142 89  79  71  53  83  55  47  44  24
Lymphogranuloma venereum 732 586 590  787  835  604  434  448  500  762
Malaria 93 99 118  73  72  71  85  132  234  522
Measles (rubeola) 458,083 385,156 481,530 423,919 441,703 406,162 763,094 486,799 611,936 555,156
Meningococcal disease 2,826 2,470 2,150  2,232  2,259  2,180  2,581  2,691  2,735  3,455
Murine typhus fever 30 35  32  46  68  51  71  113  98  135



























Pertussis (whooping cough) 13,005 17,135 17,749  11,468  14,809  40,005  32,148  28,295  31,732  62,786 
Plague – 1  –  3  2  4  –  1  1  –
Poliomyelitis, total 122 449  910  1,312  3,190  8,425  5,787  5,485  15,140  28,985
 Paralytic 106 396  762  988  2,525  6,289  3,697  2,499  7,911  13,850 
Psittacosis 53 76  79  102  113  147  158  278  568  334
Rabies, animal 4,780 3,929  3,732 3,599  3,567  4,177  4,787  4,542  5,681  5,799
Rabies, human
¶
1 1  2  3  2  7  5  5  10  4
Rheumatic fever, acute 7,491 7,561 7,977  10,470  9,022  8,285  6,889 6,427  6,562 †
Rocky Mountain spotted fever 277 216  240  219  204  199  243  240  293  295
Salmonellosis, excluding typhoid fever 17,144 15,390  9,680 8,542  6,929  6,606  6,363  6,693  6,704  5,447
Shigellosis 12,984 13,009  12,443 12,571  12,487  12,888  11,861  9,822  10,306  13,912 
Smallpox .....................................................................................Last documented case occurred in 1949......................................................................
Streptococcal sore throat and scarlet fever 402,334 342,161 315,809 338,410 315,173 334,715 264,097 226,973 176,392 147,502
Syphilis, primary and secondary 22,969 22,251  21,067 19,851  16,145  9,799  7,176  6,576  6,392  6,454
 Total, all stages 114,325 124,137 126,245 124,658 122,538 120,824 113,884 123,758 130,201 122,392
Tetanus 289 325  322 379  368  445  445  447  468  462
Trichinosis 198 208  194 306  160  227  176  178  262  264
Tuberculosis** 50,874 54,042 53,315  53,726  55,494  57,535  63,534  67,149  69,895  77,368
Tularemia 342 327  328 365  390  459  587  601  522  584
Typhoid fever 501 566  608 814  816  859  1,043  1,231  1,700  1,704 
Yellow fever ......................................................................Last indigenous case reported 1911; last imported, 1924.......................................................
 *Includes Meningitis, other, for some states. 
†
Not previously notifiable nationally.
§
Data includes both infectious and serum hepatitis.
¶
Registered deaths, 1955–1961.



























Disease 1954 1953 1952 1951 1950 1949 1948 1947 1946 1945
Amebiasis 3,523 4,444  4,280 3,550  4,568  5,543  4,871  3,365  4,093  3,412
Anthrax 22 45  47 60  49  54  60  69  40  40
Botulism 18 18  18 33  20  24  39  44..............................NA ...........
Brucellosis 1,823 2,032  2,537 3,139  3,510  4,235  4,991  6,321  5,887  5,049 
Chancroid* 3,003 3,338  3,738 4,233  4,977  6,707  7,661  9,515  7,091  5,515
Cholera – –  – –  –  –  –  –  –  –
Dengue 6 8  5 16  26  46  24  35  40  106
Diphtheria 2,041 2,355  2,960 3,983  5,796  7,969  9,493  12,262  16,354  18,675
Encephalitis, acute infectious (primary) 2,606 1,935 1,912 1,123  1,135  903  730  785  728  785
Gonorrhea* 242,050 238,340 244,957 254,470 286,746 317,950 345,501 380,666 368,020 287,181
Granuloma inguinale* 618 667  951 1,352  1,783  2,402  2,469  2,330  2,232  1,857
Hansen disease (leprosy) 56 60  57 57  44  41  63  56  43  40
Hepatitis, infectious
†
 50,093 33,700  17,428 7,349  2,820  2,027  709  1,092..............................NA ............
Leptospirosis 48 42  62  9  30  17  18  14..............................NA ............
Lymphogranuloma venereum* 875 983  1,200 1,300 1,427 1,925  2,429  2,526  2,603  2,631
Malaria 715 1,310 7,023 5,600 2,184 4,151 9,606 15,116 48,610 62,763
Measles (rubeola) 682,720 449,146 683,077 530,118 319,124 625,281 615,104 222,375 659,843 146,013
Meningococcal disease 4,436 5,077  4,884 4,164  3,788  3,519  3,376  3,420  5,693  8,208
Murine typhus fever 163 221  205  378  685  985  1,171  2,050  3,365  5,193



























Pertussis (whooping cough) 60,886 37,129  45,030 68,687 120,718  69,479  74,715 156,517 109,860 133,792
Plague – –  –  1  3  3  –  1  –  –
Poliomyelitis, total 38,476 35,592 57,879 28,386  33,300  42,033 27,726 10,827 25,698 13,624
Psittacosis 563 169  135  25  26  35  32  27  26  27
Rabies, animal
§
7,297 8,903  8,445 8,008  7,901  7,587  8,495  8,920  10,850  9,928
Rabies, human
¶
13 12  24  18  18  10  24  26  34  43
Rocky Mountain spotted fever 294 313  327 347  464  570  547  596  587  472
Salmonellosis, excluding typhoid fever 5,375 3,946 2,596 1,773  1,233  1,243  882  951  723  649
Shigellosis 13,846 16,533  23,197 32,215  23,367  29,080  23,753  17,048  24,286  34,943
Smallpox - –  –  –  –  49  57  176  337  346
Streptococcal sore throat and scarlet fever 147,785 132,935 113,677 84,151  64,494  87,220  91,295  93,595 125,511 185,570
Syphilis, primary and secondary* 7,147 8,637  10,449 14,485  23,939  41,942  68,174  93,545  94,957  77,007
 Total, all stages* 130,697 148,573 167,762 174,924 217,558 256,463 314,313 355,592 963,647 359,114
Tetanus 524 506  484 506  486  579  601  560..............................NA ............
Trichinosis 277 395  367 393 327 353 487 451..............................NA ............
Tuberculosis** 79,775 84,304 86,700 118,491 121,742 134,865 137,006 134,946 119,256 114,931
Tularemia 681 601  668  702  927  1,179  1,086  1,401  1,355  900
Typhoid fever 2,169 2,252  2,341 2,128  2,484  2,795  2,840  3,075  3,268  4,211
Yellow fever ......................................................................Last indigenous case reported 1911; last imported, 1924.......................................................
 *Data were reported for fiscal years 1945–1946; data were reported by calendar year beginning in 1947.
†
Data for 1953 and 1954 includes serum hepatitis.
§
Data for 1945–1951 from Bureau of Animal Industry, U.S. Department of Agriculture, Agricultural Research Administration.
¶
Registered deaths.



























Cause of Death ICD* 1992 1991 1990  1989 1988  1987 1986  1985  1984 1983 
AIDS†  *042–*044 33,566 29,555 25,188 22,082 16,602 13,468 10,900  6,040 2,943 1,141
Amebiasis   006 6  5  5  4  7  9  8  10  10  21
Anthrax  022 –  –  –  –  –  –  –  –  –  –
Botulism, foodborne  005.1 1 2  4  2  1  –  1  4  4  7
Brucellosis  023 –  –  –  –  2  1  1  1  –  –
Chancroid  099.0 –  1  –  –  –  –  –  –  –  –
Cholera  001  2 2  2  –  –  1  –  1  –  –
Diphtheria  032  1 –  1  –  –  1  –  –  –  –
Encephalitis, acute infectious§ 062–064,049 126 142  167  143  133  146  230  153  168  169
Gonococcal infections  098 4  3  3  4  3  7  7  2  3  4
Granuloma inguinale  099.2 – –  –  –  –  –  –  –  –  –
Haemophilus influenzae, invasive  041.5 16  17  16  16  25  25  21  22  14  11
Hansen disease (leprosy)  030 2  –  3  4  –  1  1  2  6  3
Hepatitis, viral, infectious (Hep A) 070.0,070.1 82  71  76  88  70  77  65  80  77  82 
Hepatitis, viral, serum (Hep B) 070.2,070.3 903 912  816  711  621  595  557  490  465  438
Hepatitis, viral, other and unsp. 070.4–070.9 1,016  857  686  717  599  510  384  372  327  343
Leptospirosis  100 2 1  2  –  2  1  –  4  –  5 
Lymphogranuloma venereum  099.1 1 1  2  2  –  –  –  3  –  –
Malaria  084 8  4  3  11  7  5  5  13  7  3 
Measles (rubeola)  055 4  27  64  32  3  2  2  4  1  4 
Meningococcal disease  036 201  198  215  273  278  258  286  257  300  299
Mumps  072 –  1  1  3  2  2  –  –  1  2
Murine typhus fever  081.0 – –  –  1  –  –  –  1  –  –
Pertussis (whooping cough)  033 5 –  12  12  4  1  6  4  7  5 
Plague  020 1 –  –  –  –  1  –  1  3  5 
Poliomyelitis, total 045.0–045.9 –  1  –  –  1  –  –  3  –  –
Psittacosis   073 4  –  2  1  1  2  –  1  –  1 
Rabies, human  071 1 3  1  1  –  1  –  –  2  2 
Rheumatic fever, acute  390–392 100  89  66  70  76  42  60  56  70  87 
Rocky Mountain spotted fever  082.0 13 13  20  10  20  21  19  22  34  35
Rubella (German measles)  056 1 1  8  4  1  –  1  1  1  3
Salmonellosis, incl. paratyphoid fever  002.1–002.9,003 47  53  80  99  66  105  102  117  90  82
Shigellosis  004 8 10  10  16  8  13  4  17  8  9
Syphilis  090–097 91 93  106  105  85  98  80  80  105  121
Tetanus  037 9  11  11  9  17  16  22  23  20  22
Trichinosis  124 –  –  –  1  –  –  –  1  –  –
Tuberculosis (all forms)  010–018 1,705 1,713  1,810  1,970  1,921  1,755  1,782  1,752 1,729 1,779
Tularemia  021 3 2  1  1  2  4  4  3  2  1
Typhoid fever  002.0 – 1  1  –  –  2  2  –  –  3
Varicella (chickenpox)  052 100 81  120  89  83  89  47  68  53  57 
TABLE 7. NOTIFIABLE DISEASES — deaths from specified notifiable diseases, United States, 1983–1992. (Numbers in ICD
column refer to the category numbers listed in the Ninth Revision of the International Classification of Diseases, 1975.)
*Numbers in ICD column refer to the category numbers listed in the Ninth Revision of the International Classification of Diseases, 1975. (The asterisks in the ICD column
pertain to the ICD code, not a footnote. They indicate that the numbers are not part of the ICD but were introduced for use in the United States.)
†
For 1983–1986, deaths are estimated from death certificates with mention of conditions coded to deficiency of cell-mediated immunity (ICD-9 No. 279.1). Includes other
human immunodeficiency virus (HIV)-related deaths and other diseases classifiable as deficiency of cell-mediated immunity.
§
Arthropod-borne encephalitis and other nonarthropod-borne viral diseases of the central nervous system.
Source: National Center for Health Statistics System, 1983–1992. Deaths are classified according to the Ninth Revision, ICD.
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Alabama John P. Lofgren, MD William J. Callan, PhD
Alaska John P. Middaugh, MD Gregory V. Hayes
Arizona Lawrence Sands, DO, MPH Barbara J. Erickson, PhD
Arkansas Thomas C. McChesney, DVM Michael G. Foreman
California Duc J. Vugia, MD, MPH Michael G. Volz, PhD
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Connecticut James L. Hadler, MD, MPH Sanders F. Hawkins, PhD 
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District of Columbia Martin E. Levy, MD, MPH James B. Thomas, ScD
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Georgia Kathleen E. Toomey, MD, MPH Elizabeth A. Franko, DrPH
Hawaii Richard L. Vogt, MD Vernon K. Miyamoto, PhD
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Illinois Byron J. Francis, MD, MPH David F. Carpenter, PhD
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Maryland Diane M. Dwyer, MD J. Mehsen Joseph, PhD
Massachusetts Alfred DeMaria, Jr, MD Ralph J. Timperi, MPH
Michigan Kenneth R. Wilcox, Jr, MD, DrPH Robert Martin, DrPH
Minnesota Michael T. Osterholm, PhD, MPH Pauline Bouchard, JD, MPH
Mississippi Mary Currier, MD, MPH Joe O. Graves, PhD
Missouri H. Denny Donnell, Jr, MD, MPH Eric C. Blank, DrPH
Montana Todd D. Damrow, PhD, MPH Douglas O. Abbott, PhD
Nebraska Thomas J. Safranek, MD John D. Blosser
Nevada Randall L. Todd, DrPH Arthur F. DiSalvo, MD
New Hampshire M. Geoffrey Smith, MD, MPH Veronica C. Malmberg, MSN
New Jersey Kenneth C. Spitalny, MD Shahiedy I. Shahied, PhD
New Mexico C. Mack Sewell, DrPH, MS Loris W. Hughes, PhD
New York City Benjamin A. Mojica, MD, MPH Stanley Reimer
New York State Dale L. Morse, MD, MS Lawrence S. Sturman, MD, PhD
North Carolina J. Michael Moser, MD, MPH Samuel N. Merritt, DrPH
North Dakota Larry A. Shireley, MS, MPH James D. Anders, MPH
Ohio Thomas J. Halpin, MD, MPH Kathleen L. Meckstroth, DrPH
Oklahoma Joe P. Mallonee, MPH (Acting) Garry L. McKee, PhD
Oregon David Fleming, MD Michael R. Skeels, PhD, MPH
Pennsylvania James T. Rankin, Jr, DVM, PhD, MPH Bruce Kieger, DrPH
Rhode Island Bela T. Matyas, MD, MPH Walter Combs, PhD
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Virginia Grayson B. Miller, Jr, MD James L. Pearson, DrPH
Washington Paul Stehr-Green, DrPH, MPH Jon M. Counts, DrPH
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Wyoming Gayle L. Miller, DVM, MPH Carl H. Blank, DrPH
American Samoa Edgar C. Reid, DSM, MPH     —
Federated States of
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Guam Robert L. Haddock, DVM, MPH Jeff Benjamin (Acting)
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Puerto Rico Carmen C. Deseda, MD Adolpho Firpo-Betancourt, MD
Virgin Islands Donna M. Green, MD Norbert Mantor, PhD
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